BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chou YE, Yang PJ, Lin CY, Chen YY, Chiang WL, Lin PX, Huang ZY, Huang M, Ho YC, Yang SF. The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics. Int J Environ Res Public Health 2020;17:E7247. [PMID: 33023053 DOI: 10.3390/ijerph17197247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Deng B, Tang X, Wang Y. Role of microRNA-129 in cancer and non-cancerous diseases (Review). Exp Ther Med 2021;22:918. [PMID: 34335879 DOI: 10.3892/etm.2021.10350] [Reference Citation Analysis]
2 Cao H, Guo D. Association of High-Mobility Group Box 1 (HMGB1) Gene Polymorphisms with Susceptibility and Better Survival Prognosis in Chinese Han Neonatal Necrotizing Enterocolitis. Med Sci Monit 2021;27:e930015. [PMID: 34054124 DOI: 10.12659/MSM.930015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chou YE, Hsieh MJ, Wang SS, Lin CY, Chen YY, Ho YC, Yang SF. The impact of receptor of advanced glycation end-products polymorphisms on prostate cancer progression and clinicopathological characteristics. J Cell Mol Med 2021;25:10761-9. [PMID: 34708514 DOI: 10.1111/jcmm.17025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]